KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Gains from Sales and Divestitures (2019 - 2021)

Historic Gains from Sales and Divestitures for Twist Bioscience (TWST) over the last 3 years, with Q4 2021 value amounting to $62000.0.

  • Twist Bioscience's Gains from Sales and Divestitures rose 1481.48% to $62000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $62000.0, marking a year-over-year increase of 1481.48%. This contributed to the annual value of $237000.0 for FY2021, which is 3314.61% up from last year.
  • Twist Bioscience's Gains from Sales and Divestitures amounted to $62000.0 in Q4 2021, which was up 1481.48% from $237000.0 recorded in Q3 2021.
  • In the past 5 years, Twist Bioscience's Gains from Sales and Divestitures ranged from a high of $237000.0 in Q3 2021 and a low of $8000.0 during Q3 2019
  • Over the past 3 years, Twist Bioscience's median Gains from Sales and Divestitures value was $121000.0 (recorded in 2021), while the average stood at $122888.9.
  • As far as peak fluctuations go, Twist Bioscience's Gains from Sales and Divestitures skyrocketed by 212500.0% in 2020, and later surged by 168.07% in 2021.
  • Twist Bioscience's Gains from Sales and Divestitures (Quarter) stood at $8000.0 in 2019, then soared by 575.0% to $54000.0 in 2020, then grew by 14.81% to $62000.0 in 2021.
  • Its last three reported values are $62000.0 in Q4 2021, $237000.0 for Q3 2021, and $178000.0 during Q2 2021.